You are here

Our science / Clinical Trials / Find a Trial / NCT00143416

Long Term Study With B2036-PEG

Back to Search Print Save as PDF Bookmark Trial

NCT00143416

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Kobe City, Hyogo Pref, 650-0017 Japan
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Acromegaly
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients with acromegaly who have received at least one dose of B2036-PEG in the
preceding study (A6291009).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Switching to other therapeutic methods for acromegaly

NCT00143416
Pfizer
Completed
Long Term Study With B2036-PEG

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now